The Oxford University company secures £2.3m in Series A funding to translate image management platform for the consumer market.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Scenic Biotech’s ‘genetic off-switch’ for disease secures major investment to accelerate development
Scenic Biotech, an international collaboration between Oxford University and Netherlands Cancer Institute, aims to unlock genetic potential in tackling cancer and other diseases with new funding.
Colwiz, a 2013 OUI Incubator company, and Oxford Gene Technology, a spinout 20 years in the making, both make successful trade sales.
Roundup of news, deals, and data from OUI for Q1 2017.
The Oxford University spinout leads newly formed DRIVEN consortium in most ambitious autonomous vehicle trials worldwide to date.
Spinout Oxford Cancer Biomarkers announces strategic collaboration with My-BioMed Biotechnology Co. Ltd, providing precision medicine to clinicians and patients in China
SpyBiotech, an Oxford University spinout developing a molecular superglue for rapid development of vaccines targeting a range of diseases, secures £4m seed funding at launch, led by Oxford Sciences Innovation with participation from GV.
Oxford Cancer Biomarker’s ColoTox test will now be available to UK patients considering chemotherapy.